Canada and MENA PCR Diagnostic Kits Market Research Report Forecast to 2032

PCR diagnostic kits are medical tools that utilize the polymerase chain reaction (PCR) method to identify and amplify specific DNA or RNA sequences, helping to detect and diagnose infections, genetic conditions, or other diseases. These kits typically contain reagents, primers, and enzymes necessary for the PCR process and are used in clinical laboratories and healthcare settings to analyze patient samples for the presence of pathogens or genetic markers.

The Canada and MENA PCR diagnostic kits market is burgeoning owing to factors such as rising incidences of chronic and infectious diseases and advancements in PCR-based technology products. However, a lack of skilled workers to interpret the data and the availability of alternative technologies are restraining the growth of the market. Nonetheless, the growing adoption of PCR diagnostic kits for early diagnosis and the increasing demand for personalized medicine in the coming years will present lucrative growth opportunities for the Canada and MENA PCR diagnostic kits market.

Market Segmentation

Based on the technology, the Canada and MENA PCR diagnostic kits market has been segmented into quantitative PCR (qPCR), and qualitative PCR. Quantitative PCR is further segmented into viral load quantification, gene expression.

Based on the application, the Canada and MENA PCR diagnostic kits market has been segmented into hemato-oncology, infectious diseases, thrombophilia, neurological disease, cardiovascular disease, and others.

In terms of end user, Canada and MENA PCR diagnostic kits market has been segmented into hospitals & clinics, diagnostic laboratories, and others.

Based on region, the PCR diagnostic kits market has been segmented into Canada and MENA. MENA is further segmented into UAE, Saudi Arabia, Kuwait, Iran, Qatar, Bahrain, Egypt, Morocco, Algeria, Jordan, and the Rest of MENA. MENA accounted for the largest market share of 53.12% in 2022 and is anticipated to reach USD 2,037.92 million by 2032, registering a faster CAGR of 6.85% during the forecast period.

Major Players

These include Bio-Rad Laboratories, Inc, BioMerieux , Thermo Fisher Scientific Inc, Agilent Technologies Inc, F. Hoffmann-La Roche Ltd, Merck KGaA , and QIAGEN.

1EXECUTIVE SUMMARY

2MARKET INTRODUCTION

2.1DEFINITION
2.2SCOPE OF THE STUDY
2.3RESEARCH OBJECTIVE
2.4MARKET STRUCTURE

3RESEARCH METHODOLOGY

3.1OVERVIEW
3.2DATA FLOW
- 3.2.1DATA MINING PROCESS
3.3PURCHASED DATABASE:
3.4SECONDARY SOURCES:
- 3.4.1SECONDARY RESEARCH DATA FLOW:
3.5PRIMARY RESEARCH:
- 3.5.1PRIMARY RESEARCH DATA FLOW:
- 3.5.2PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.6APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1REVENUE ANALYSIS APPROACH
3.7DATA FORECASTING
- 3.7.1DATA FORECASTING TECHNIQUE
3.8DATA MODELING
- 3.8.1MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2DATA MODELING:
3.9TEAMS AND ANALYST CONTRIBUTION

4MARKET DYNAMICS

4.1INTRODUCTION
4.2DRIVERS
- 4.2.1INCREASING INCIDENCES OF INFECTIOUS DISEASES IN CANADA AND MENA
- 4.2.2TECHNOLOGICAL ADVANCEMENTS IN PCR-BASED DIAGNOSTIC KITS
4.3RESTRAINTS
- 4.3.1DEARTH OF SKILLED PROFESSIONALS
4.4OPPORTUNITY
- 4.4.1GROWING ADOPTION OF PCR DIAGNOSTIC KITS FOR EARLY DIAGNOSIS
4.5FUTURE TRENDS OF PCR-BASED DIAGNOSTIC KITS MARKET

5MARKET FACTOR ANALYSIS

5.1VALUE CHAIN ANALYSIS
- 5.1.1R&D
- 5.1.2MANUFACTURING
- 5.1.3DISTRIBUTION AND SALES
- 5.1.4POST-SALES MONITORING
5.2PORTER'S FIVE FORCES MODEL
- 5.2.1THREAT OF NEW ENTRANTS
- 5.2.2BARGAINING POWER OF SUPPLIERS
- 5.2.3THREAT OF SUBSTITUTES
- 5.2.4BARGAINING POWER OF BUYERS
- 5.2.5INTENSITY OF RIVALRY
5.3IMPACT OF COVID-19 ON THE CANADA AND MENA PCR DIAGNOSTIC KITS MARKET
- 5.3.1IMPACT ON SUPPLY CHAIN
- 5.3.2IMPACT ON DEMAND AND SUPPLY
5.4TOTAL NUMBER OF PCR TESTS PERFORMED IN CANADA AND MENA (2022)

6CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY

6.1OVERVIEW
6.2QUANTITATIVE PCR (QPCR)
- 6.2.1VIRAL LOAD QUANTIFICATION
- 6.2.2GENE EXPRESSION
- 6.2.3OTHERS
6.3QUALITATIVE PCR

7CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY APPLICATION

7.1OVERVIEW
7.2HEMATO-ONCOLOGY
7.3INFECTIOUS DISEASES
- 7.3.1COVID-19
- 7.3.2FLU
- 7.3.3TUBERCULOSIS AND DRUG-RESISTANT TBA
- 7.3.4MENINGITIS
- 7.3.5HIV
- 7.3.6HEPATITIS
- 7.3.7OTHERS
7.4THROMBOPHILIA
7.5NEUROLOGICAL DISEASE
7.6CARDIOVASCULAR DISEASE
7.7OTHERS

8CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY END USER

8.1OVERVIEW
8.2HOSPITALS & CLINICS
8.3DIAGNOSTIC LABORATORIES
8.4OTHERS

9CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY REGION

9.1OVERVIEW
9.2CANADA
9.3MIDDLE EAST & NORTH AFRICA (MENA)
- 9.3.1UAE
- 9.3.2SAUDI ARABIA
- 9.3.3KUWAIT
- 9.3.4IRAN
- 9.3.5QATAR
- 9.3.6BAHRAIN
- 9.3.7EGYPT
- 9.3.8MOROCCO
- 9.3.9ALGERIA
- 9.3.10JORDAN
- 9.3.11SYRIA
- 9.3.12LEBANON
- 9.3.13IRAQ
- 9.3.14REST OF MIDDLE EAST & NORTH AFRICA

10COMPETITIVE LANDSCAPE

10.1INTRODUCTION
10.2MARKET SHARE ANALYSIS, 2022
10.3COMPETITOR DASHBOARD
10.4PUBLIC PLAYERS STOCK SUMMARY
10.5COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
10.6KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.6.1PRODUCT LAUNCH

11COMPANY PROFILES

11.1THERMO FISHER SCIENTIFIC INC
- 11.1.1COMPANY OVERVIEW
- 11.1.2FINANCIAL OVERVIEW
- 11.1.3PRODUCTS OFFERED
- 11.1.4KEY DEVELOPMENTS
- 11.1.5SWOT ANALYSIS
- 11.1.6KEY STRATEGY
11.2AGILENT TECHNOLOGIES, INC
- 11.2.1COMPANY OVERVIEW
- 11.2.2FINANCIAL OVERVIEW
- 11.2.3PRODUCTS OFFERED
- 11.2.4KEY DEVELOPMENTS
- 11.2.5SWOT ANALYSIS
- 11.2.6KEY STRATEGIES
11.3F. HOFFMANN-LA ROCHE LTD
- 11.3.1COMPANY OVERVIEW
- 11.3.2FINANCIAL OVERVIEW
- 11.3.3PRODUCTS OFFERED
- 11.3.4KEY DEVELOPMENTS
- 11.3.5SWOT ANALYSIS
- 11.3.6KEY STRATEGIES
11.4MERCK KGAA
- 11.4.1COMPANY OVERVIEW
- 11.4.2FINANCIAL OVERVIEW
- 11.4.3PRODUCTS OFFERED
- 11.4.4KEY DEVELOPMENTS
- 11.4.5KEY STRATEGIES
11.5QIAGEN
- 11.5.1COMPANY OVERVIEW
- 11.5.2FINANCIAL OVERVIEW
- 11.5.3PRODUCTS OFFERED
- 11.5.4KEY DEVELOPMENTS
- 11.5.5KEY STRATEGIES
11.6BIO-RAD LABORATORIES, INC
- 11.6.1COMPANY OVERVIEW
- 11.6.2FINANCIAL OVERVIEW
- 11.6.3PRODUCTS OFFERED
- 11.6.4KEY DEVELOPMENTS
- 11.6.5SWOT ANALYSIS
- 11.6.6KEY STRATEGIES
11.7BIOMERIEUX
- 11.7.1COMPANY OVERVIEW
- 11.7.2FINANCIAL OVERVIEW
- 11.7.3PRODUCTS OFFERED
- 11.7.4KEY DEVELOPMENTS
- 11.7.5SWOT ANALYSIS
- 11.7.6KEY STRATEGIES
11.8ENZO LIFE SCIENCES, INC
- 11.8.1COMPANY OVERVIEW
- 11.8.2FINANCIAL OVERVIEW
- 11.8.3PRODUCTS OFFERED
- 11.8.4KEY DEVELOPMENTS
- 11.8.5KEY STRATEGIES
11.9PROMEGA CORPORATION
- 11.9.1COMPANY OVERVIEW
- 11.9.2FINANCIAL OVERVIEW
- 11.9.3PRODUCTS OFFERED
- 11.9.4KEY DEVELOPMENTS
- 11.9.5KEY STRATEGIES
11.10PRIMERDESIGN LTD
- 11.10.1COMPANY OVERVIEW
- 11.10.2FINANCIAL OVERVIEW
- 11.10.3PRODUCTS OFFERED
- 11.10.4KEY DEVELOPMENTS
- 11.10.5KEY STRATEGIES

12DATA CITATIONS

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 32
TABLE 2 TOTAL NUMBER OF PCR TESTS PERFORMED IN CANADA AND MENA (2022) 45
TABLE 3 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 48
TABLE 4 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY REGION, 2019-2032 (USD MILLION) 48
TABLE 5 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 49
TABLE 6 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR VIRAL LOAD QUANTIFICATION, BY REGION, 2019-2032 (USD MILLION) 49
TABLE 7 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR GENE EXPRESSION, BY REGION, 2019-2032 (USD MILLION) 49
TABLE 8 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION) 50
TABLE 9 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR QUALITATIVE PCR, BY REGION, 2019-2032 (USD MILLION) 50
TABLE 10 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY APPLICATION, 2019-2032 (USD MILLION) 52
TABLE 11 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR HEMATO-ONCOLOGY, BY REGION, 2019-2032 (USD MILLION) 53
TABLE 12 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY REGION, 2019-2032 (USD MILLION) 53
TABLE 13 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 54
TABLE 14 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR COVID-19, BY REGION, 2019-2032 (USD MILLION) 54
TABLE 15 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR FLU, BY REGION, 2019-2032 (USD MILLION) 55
TABLE 16 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR TUBERCULOSIS AND DRUG-RESISTANT TBA, BY REGION, 2019-2032 (USD MILLION) 55
TABLE 17 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR MENINGITIS, BY REGION, 2019-2032 (USD MILLION) 55
TABLE 18 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR HIV, BY REGION, 2019-2032 (USD MILLION) 56
TABLE 19 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR HEPATITIS, BY REGION, 2019-2032 (USD MILLION) 56
TABLE 20 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION) 56
TABLE 21 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR THROMBOPHILIA, BY REGION, 2019-2032 (USD MILLION) 57
TABLE 22 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR NEUROLOGICAL DISEASE, BY REGION, 2019-2032 (USD MILLION) 57
TABLE 23 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR CARDIOVASCULAR DISEASE, BY REGION, 2019-2032 (USD MILLION) 57
TABLE 24 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION) 58
TABLE 25 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY END USER, 2019-2032 (USD MILLION) 60
TABLE 26 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION) 61
TABLE 27 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2019-2032 (USD MILLION) 61
TABLE 28 CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION) 62
TABLE 29 CANADA AND MENA: PCR DIAGNOSTIC KITS MARKET, BY REGION, 2019-2032 (USD MILLION) 63
TABLE 30 CANADA: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 65
TABLE 31 CANADA: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 65
TABLE 32 CANADA: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 66
TABLE 33 CANADA: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 66
TABLE 34 CANADA: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 67
TABLE 35 MENA: PCR DIAGNOSTIC KITS MARKET, BY COUNTRY, 2019-2032 (USD MILLION) 70
TABLE 36 MENA: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 71
TABLE 37 MENA: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 71
TABLE 38 MENA: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 71
TABLE 39 MENA: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 72
TABLE 40 MENA: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 72
TABLE 41 UAE: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 72
TABLE 42 UAE: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 73
TABLE 43 UAE: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 73
TABLE 44 UAE: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 74
TABLE 45 UAE: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 74
TABLE 46 SAUDI ARABIA: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 74
TABLE 47 SAUDI ARABIA: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 75
TABLE 48 SAUDI ARABIA: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 75
TABLE 49 SAUDI ARABIA: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 76
TABLE 50 SAUDI ARABIA: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 76
TABLE 51 KUWAIT: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 76
TABLE 52 KUWAIT: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 77
TABLE 53 KUWAIT: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 77
TABLE 54 KUWAIT: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 77
TABLE 55 KUWAIT: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 78
TABLE 56 IRAN: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 78
TABLE 57 IRAN: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 78
TABLE 58 IRAN: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 79
TABLE 59 IRAN: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 79
TABLE 60 IRAN: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 79
TABLE 61 QATAR: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 80
TABLE 62 QATAR: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 80
TABLE 63 QATAR: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 80
TABLE 64 QATAR: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 81
TABLE 65 QATAR: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 81
TABLE 66 BAHRAIN: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 81
TABLE 67 BAHRAIN: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 82
TABLE 68 BAHRAIN: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 82
TABLE 69 BAHRAIN: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 83
TABLE 70 BAHRAIN: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 83
TABLE 71 EGYPT: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 83
TABLE 72 EGYPT: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 84
TABLE 73 EGYPT: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 84
TABLE 74 EGYPT: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 84
TABLE 75 EGYPT: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 85
TABLE 76 MOROCCO: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 85
TABLE 77 MOROCCO: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 85
TABLE 78 MOROCCO: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 86
TABLE 79 MOROCCO: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 86
TABLE 80 MOROCCO: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 86
TABLE 81 ALGERIA: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 87
TABLE 82 ALGERIA: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 87
TABLE 83 ALGERIA: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 87
TABLE 84 ALGERIA: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 88
TABLE 85 ALGERIA: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 88
TABLE 86 JORDAN: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 88
TABLE 87 JORDAN: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 89
TABLE 88 JORDAN: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 89
TABLE 89 JORDAN: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 89
TABLE 90 JORDAN: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 90
TABLE 91 SYRIA: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 90
TABLE 92 SYRIA: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 90
TABLE 93 SYRIA: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 91
TABLE 94 SYRIA: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 91
TABLE 95 SYRIA: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 91
TABLE 96 LEBANON: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 92
TABLE 97 LEBANON: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 92
TABLE 98 LEBANON: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 92
TABLE 99 LEBANON: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 93
TABLE 100 LEBANON: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 93
TABLE 101 IRAQ: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 93
TABLE 102 IRAQ: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 94
TABLE 103 IRAQ: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 94
TABLE 104 IRAQ: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, BY TYPE, 2019-2032 (USD MILLION) 94
TABLE 105 IRAQ: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 95
TABLE 106 REST OF MIDDLE EAST & NORTH AFRICA: PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2019-2032 (USD MILLION) 95
TABLE 107 REST OF MIDDLE EAST & NORTH AFRICA: PCR DIAGNOSTIC KITS MARKET, FOR QUANTITATIVE PCR (QPCR), BY TYPE, 2019-2032 (USD MILLION) 95
TABLE 108 REST OF MIDDLE EAST & NORTH AFRICA: PCR DIAGNOSTIC KITS MARKET BY APPLICATION, 2019-2032 (USD MILLION) 96
TABLE 109 REST OF MIDDLE EAST & NORTH AFRICA: PCR DIAGNOSTIC KITS MARKET, FOR INFECTIOUS DISEASES, 96
TABLE 110 BY TYPE, 2019-2032 (USD MILLION) 96
TABLE 111 REST OF MIDDLE EAST & NORTH AFRICA: PCR DIAGNOSTIC KITS MARKET BY END USER, 2019-2032 (USD MILLION) 97
TABLE 112 PUBLIC PLAYERS STOCK SUMMARY 100
TABLE 113 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL 100
TABLE 114 PRODUCT LAUNCH 101
TABLE 115 THERMO FISHER SCIENTIFIC INC: DISEASE PRODUCTS OFFERED 103
TABLE 116 AGILENT TECHNOLOGIES, INC: PRODUCTS OFFERED 106
TABLE 117 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 109
TABLE 118 MERCK KGAA: PRODUCTS OFFERED 112
TABLE 119 QIAGEN: PRODUCTS OFFERED 116
TABLE 120 BIO-RAD LABORATORIES, INC: PRODUCTS OFFERED 118
TABLE 121 BIOMERIEUX: PRODUCTS OFFERED 121
TABLE 122 BIOMERIEUX: KEY DEVELOPMENTS 122
TABLE 123 ENZO LIFE SCIENCES, INC: PRODCUTS OFFERED 125
TABLE 124 PROMEGA CORPORATION: PRODUCTS OFFERED 127
TABLE 125 PRIMERDESIGN LTD: PRODCUTS OFFERED 129

LIST OF FIGURES

FIGURE 1CANADA & MENA PCR DIAGNOSTIC KITS MARKET: STRUCTURE20
FIGURE 2CANADA AND MENA PCR DIAGNOSTIC KITS MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)36
FIGURE 3DRIVER IMPACT ANALYSIS (2023-2032)37
FIGURE 4RESTRAINT IMPACT ANALYSIS (2022-2032)38
FIGURE 5VALUE CHAIN ANALYSIS OF THE CANADA AND MENA PCR DIAGNOSTIC KITS MARKET40
FIGURE 6PORTER'S FIVE FORCES ANALYSIS: CANADA AND MENA PCR DIAGNOSTIC KITS MARKET43
FIGURE 7CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, TECHNOLOGY SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)47
FIGURE 8CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY TECHNOLOGY, 2022 & 2032 (USD MILLION)47
FIGURE 9CANADA AND MENA PCR DIAGNOSTIC KITS MARKET SHARE (%), BY TECHNOLOGY, 202248
FIGURE 10CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)51
FIGURE 11CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION)52
FIGURE 12CANADA AND MENA PCR DIAGNOSTIC KITS MARKET SHARE (%), BY APPLICATION, 202253
FIGURE 13CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, END USER SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)59
FIGURE 14CANADA AND MENA PCR DIAGNOSTIC KITS MARKET, BY END USER, 2022 & 2032 (USD MILLION)60
FIGURE 15CANADA AND MENA PCR DIAGNOSTIC KITS MARKET SHARE (%), BY END USER, 202261
FIGURE 16CANADA AND MENA: PCR DIAGNOSTIC KITS MARKET, BY REGION, 2022 & 2032 (USD MILLION)63
FIGURE 17CANADA AND MENA: PCR DIAGNOSTIC KITS MARKET SHARE (%), BY REGION, 202264
FIGURE 18CANADA MARKET ANALYSIS: PCR DIAGNOSTIC KITS MARKET, 2019-2032 TREND ANALYSIS64
FIGURE 19CANADA MARKET ANALYSIS: PCR DIAGNOSTIC KITS MARKET, 2019-2032 (USD MILLION)65
FIGURE 20MENA MARKET ANALYSIS: PCR DIAGNOSTIC KITS MARKET, 2019-2032 TREND ANALYSIS68
FIGURE 21MENA: PCR DIAGNOSTIC KITS MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)69
FIGURE 22MENA: PCR DIAGNOSTIC KITS MARKET SHARE (%), BY COUNTRY, 202270
FIGURE 23CANADA AND MENA PCR DIAGNOSTIC KITS MARKET PLAYERS: COMPETITIVE ANALYSIS, 202298
FIGURE 24COMPETITOR DASHBOARD: CANADA AND MENA PCR DIAGNOSTIC KITS MARKET99
FIGURE 25THERMO FISHER SCIENTIFIC INC: FINANCIAL OVERVIEW SNAPSHOT103
FIGURE 26THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS104
FIGURE 27AGILENT TECHNOLOGIES, INC: FINANCIAL OVERVIEW SNAPSHOT106
FIGURE 28AGILENT TECHNOLOGIES, INC: SWOT ANALYSIS107
FIGURE 29F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT109
FIGURE 30F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS110
FIGURE 31MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT112
FIGURE 32QIAGEN: FINANCIAL OVERVIEW SNAPSHOT115
FIGURE 33BIO-RAD LABORATORIES, INC: FINANCIAL OVERVIEW SNAPSHOT118
FIGURE 34BIO-RAD LABORATORIES, INC: SWOT ANALYSIS119
FIGURE 35BIOMERIEUX: FINANCIAL OVERVIEW SNAPSHOT121
FIGURE 36BIOMERIEUX: SWOT ANALYSIS123